The FTC administrative complaint and the currently encoded proposed consent agreements involving pharmacy benefit managers and affiliated group purchasing organizations.
Grouping basisThe complaint and two proposed consent agreements are grouped by their shared FTC administrative matter, Docket No. 9437; the broader PBM market study remains separate.
The FTC brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving Caremark, Express Scripts, OptumRx, and affiliated GPOs.
Adds alleged conduct and patient-harm context to the PBM profile. The allegations remain distinct from the descriptive concentration evidence and do not supply missing individual shares.
The FTC announced a proposed consent agreement with Express Scripts and affiliated entities addressing formulary design, patient cost sharing, manufacturer compensation, plan-sponsor transparency, community-pharmacy reimbursement, and related business practices.
Records announced remedy terms in the pending administrative matter. The filing does not establish realized savings, changes in PBM market structure, or a basis for calculating the withheld market HHI.
The FTC announced a proposed consent agreement with Caremark and Zinc Health Services addressing formulary design, point-of-sale rebates, fee structures, plan-sponsor transparency, community-pharmacy reimbursement, and access to pharmacy hub services.
Records announced remedy terms in the pending administrative matter. The filing does not establish realized savings, changes in PBM market structure, or a basis for calculating the withheld market HHI.
A market link is observatory context assigned to an official record. It is not necessarily the relevant antitrust market alleged or adjudicated in the proceeding.
These are descriptive observations from separately defined market series. Timing does not identify the proceeding's effect, and missing HHI remains missing.
Shared observatory context does not establish that two proceedings concern the same conduct, parties, legal theory, market, or effect.
Reproducible proceeding packet
Reuse the chronology without flattening its evidence
Every route keeps the exact event IDs selected for this proceeding. Record rows, named-organization edges, market windows, and Atlas relationships remain separate tables.
Proceeding ID
proceeding-pbm-insulin
Profile slug
pbm-insulin-rebate-case
Docket set
Docket No. 9437
License
CC BY 4.0 compilation
Proceeding interpretation boundary
The complaint and two proposed consent agreements are grouped by their shared FTC administrative matter, Docket No. 9437; the broader PBM market study remains separate. The latest encoded stage is a data-coverage statement, not a conclusion about current posture or finality.